Abivax (ABVX) Assets: 2021-2025
- Abivax's Assets fell 55.80% to $135.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $135.4 million, marking a year-over-year decrease of 55.80%. This contributed to the annual value of $219.3 million for FY2024, which is 37.68% down from last year.
- Per Abivax's latest filing, its Assets stood at $135.4 million for Q2 2025, which was down 22.88% from $175.6 million recorded in Q1 2025.
- Abivax's Assets' 5-year high stood at $351.9 million during Q4 2023, with a 5-year trough of $77.1 million in Q4 2022.
- In the last 3 years, Abivax's Assets had a median value of $219.3 million in 2024 and averaged $237.7 million.
- Its Assets has fluctuated over the past 5 years, first skyrocketed by 356.58% in 2023, then slumped by 55.80% in 2025.
- Abivax's Assets (Quarterly) stood at $125.0 million in 2021, then crashed by 38.32% to $77.1 million in 2022, then spiked by 356.58% to $351.9 million in 2023, then plummeted by 37.68% to $219.3 million in 2024, then slumped by 55.80% to $135.4 million in 2025.
- Its last three reported values are $135.4 million in Q2 2025, $175.6 million for Q1 2025, and $219.3 million during Q4 2024.
